Form D — Iambic Therapeutics, Inc.
0001997038-25-000002 · filed Nov 21, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $124,999,970
- Reported amount sold
- $99,269,270
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Iambic Therapeutics, Inc.
- CIK
- 1997038
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO, California 92121 - Phone
- (619) 330-5499
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Miller · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Fred Manby · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Neil Josephson · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Michael Secora · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Jishnu Bhattacharjee · DirectorSan Diego, California Find on LinkedIn ↗
-
Evan Rachlin · DirectorSan Diego, California Find on LinkedIn ↗
-
R. Jacob Vogelstein · DirectorSan Diego, California Find on LinkedIn ↗
-
Mary Tagliaferri · DirectorSan Diego, California Find on LinkedIn ↗
-
William Rastetter · DirectorSan Diego, California Find on LinkedIn ↗
-
Kurt von Emster · DirectorSan Diego, California Find on LinkedIn ↗
-
Shalini Sharp · DirectorSan Diego, California Find on LinkedIn ↗
-
Pete Olson · Executive OfficerSan Diego, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗